Area of research
Radiation · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Radiotherapy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, Brain Metastases and Treatment, and Lung Cancer Diagnosis and Treatment.
Incidence and Risk Assessment of Capsular Contracture in Breast Cancer Patients following Post-Mastectomy Radiotherapy and Implant-Based Reconstruction
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
Preoperative Dose-Escalated Intensity-Modulated Radiotherapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids
Proton Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma
Biofidelic image registration for head and neck region utilizing an in-silico articulated skeleton as a transformation model
Segmentation of seventy-one anatomical structures necessary for the evaluation of guideline-conform clinical target volumes in head and neck cancers
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer
Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer
MAGELLAN (ARO 2021-3): Magnetresonanz-geführte adaptive stereotaktische Radiotherapie von Lungentumoren in ultrazentraler Lokalisation
Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer
MR-guided radiotherapy of moving targets
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
Magnetresonanzgeführte Strahlentherapie
Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool